Celon Pharma S.A. (8RP.F)

3.3600 0.0000 (0.00%) At close: 08:24AM CEST

Celon Pharma S.A.

Ogrodowa 2A
Kielpin
Lomianki 05-092
Poland
48 227 51 59 33
https://www.celonpharma.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 513

Key Executives

Name	Title	Pay	Exercised	Year Born
Dr. Maciej Wieczorek Ph.D.	CEO & President of Management Board	N/A	N/A	N/A
Bartosz Szalek	CFO & Member of the Management Board	N/A	N/A	N/A

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of pharmaceutical products and preparations. It offers drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. The company was founded in 2002 and is based in Lomianki, Poland. Celon Pharma S.A. operates as a subsidiary of Glatton Sp. z o.o.

Corporate Governance

Celon Pharma S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.